Lista de obras -

A Pandemic Influenza H1N1 Live Vaccine Based on Modified Vaccinia Ankara Is Highly Immunogenic and Protects Mice in Active and Passive Immunizations ⬇️

artículo científico publicado el 16 de agosto de 2010

A Vero Cell–Derived Whole-Virus H5N1 Vaccine Effectively Induces Neuraminidase-Inhibiting Antibodies ⬇️

artículo científico publicado el 16 de noviembre de 2011

A cell culture-derived whole-virus H5N1 vaccine induces long-lasting cross-clade protective immunity in mice which is augmented by a homologous or heterologous booster vaccination ⬇️

artículo científico publicado el 29 de junio de 2012

A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolate ⬇️

artículo científico publicado el 10 de mayo de 2012

A nonenveloped virus with a lipid envelope: hepatitis A virus as used in virus-reduction studies

artículo científico publicado en 2017

A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans

artículo científico publicado en 2011

A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.

artículo científico publicado en 2010

Antibody-enhanced hepatitis E virus nanofiltration during the manufacture of human immunoglobulin

artículo científico publicado en 2020

Blood transmission studies of prion infectivity in the squirrel monkey (Saimiri sciureus): the Baxter study

artículo científico publicado en 2015

Characterization of 100 sequential SARS-CoV-2 convalescent plasma donations

scientific article published on 25 September 2020

Characterization of source plasma from self-identified vaccinated or convalescent donors during the 2009 H1N1 pandemic

artículo científico publicado en 2018

Chikungunya virus and the safety of plasma products ⬇️

artículo científico publicado el 17 de febrero de 2012

Clinical, neuropathological and immunohistochemical features of sporadic and variant forms of Creutzfeldt-Jakob disease in the squirrel monkey (Saimiri sciureus).

artículo científico publicado en 2007

Continued use of poliovirus after eradication: hyper-attenuated strains as a safe alternative for release testing of human immunoglobulins

artículo científico publicado en 2018

Continuous Solvent/Detergent Virus Inactivation Using a Packed-Bed Reactor

scientific article published on 23 April 2019

Contribution to safety of immunoglobulin and albumin from virus partitioning and inactivation by cold ethanol fractionation: a data collection from Plasma Protein Therapeutics Association member companies

artículo científico publicado en 2011

Cytomegalovirus neutralization by hyperimmune and standard intravenous immunoglobulin preparations

artículo científico publicado en 2011

Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells

scientific article published on February 2009

Evaluation of different serological diagnostic methods for tick-borne encephalitis virus: enzyme-linked immunosorbent, immunofluorescence, and neutralization assay

artículo científico publicado en 2013

H5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer model

artículo científico publicado en 2011

Hepatitis A virus antibodies in immunoglobulin preparations

artículo científico publicado en 2009

Hepatitis E virus and the safety of plasma products: investigations into the reduction capacity of manufacturing processes

artículo científico publicado en 2015

Human IgG Subclasses: In Vitro Neutralization of and In Vivo Protection against West Nile Virus ⬇️

artículo científico publicado el 1 de diciembre de 2010

Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID mice

artículo científico publicado en 2014

Immunoglobulins and virus antibody titers: of past needs, current requirements, and future options

artículo científico publicado en 2018

Impact of vCJD on blood supply

artículo científico publicado en 2007

In reply

artículo científico publicado en 2013

Inactivation of hepatitis A variants during heat treatment (pasteurization) of human serum albumin ⬇️

artículo científico publicado el 25 de julio de 2011

Inactivation of parvovirus B19 during STIM-4 vapor heat treatment of three coagulation factor concentrates

artículo científico publicado en 2008

Influence of Extraction Protocol on Physical Properties of Parvovirus B19 DNA ⬇️

artículo científico publicado el 13 de octubre de 2010

MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 viruses

artículo científico publicado en 2014

Measles Virus Neutralizing Antibodies in Intravenous Immunoglobulins:is an Increase by Re-Vaccination of Plasma Donors possible?

artículo científico publicado en 2017

Measles virus neutralizing antibodies in immunoglobulin lots produced from plasma collected in Europe or the United States

scientific article published on 03 May 2019

Measuring the effectiveness of gaseous virus disinfectants

artículo científico publicado en 2015

Meeting Report: 2013 PDA Virus & TSE Safety Forum

artículo científico publicado en 2014

Meeting Report: 2015 PDA Virus & TSE Safety Forum

artículo científico publicado en 2016

Meeting Report: PDA Virus and TSE Safety Forum.

artículo científico

Meeting report--workshop on virus removal by filtration: trends and new developments.

artículo científico publicado en 2013

Meeting report-workshop on spike characterizations and virus removal by filtration: trends and new developments

artículo científico publicado en 2014

Molecular Basis of the Divergent Immunogenicity of Two Pediatric Tick-Borne Encephalitis Virus Vaccines

artículo científico publicado en 2015

Nanofiltration as a robust method contributing to viral safety of plasma-derived therapeutics: 20 years' experience of the plasma protein manufacturers

artículo científico publicado en 2020

Neuraminidase-Inhibiting Antibody Response to H5N1 Virus Vaccination in Chronically Ill and Immunocompromised Patients

artículo científico publicado en 2014

Neutralization of different echovirus serotypes by individual lots of intravenous immunoglobulin ⬇️

artículo científico publicado el 1 de febrero de 2011

Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins

artículo científico publicado en 2007

No SARS-CoV-2 neutralization by intravenous immunoglobulins produced from plasma collected before the 2020 pandemic

scientific article published on 17 September 2020

Parallel evaluation of broad virus detection methods

artículo científico publicado en 2014

Pre-Clinical Efficacy and Safety of Experimental Vaccines Based on Non-Replicating Vaccinia Vectors against Yellow Fever ⬇️

artículo científico publicado el 9 de septiembre de 2011

Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.

artículo científico publicado en 2012

Preparation of commercial quantities of a hyperimmune human intravenous immunoglobulin preparation against an emerging infectious disease: the example of pandemic H1N1 influenza ⬇️

artículo científico publicado el 7 de octubre de 2011

Prion removal capacity of plasma protein manufacturing processes: a data collection from PPTA member companies

artículo científico publicado en 2012

Proceedings of the 2017 Viral Clearance Symposium Session 5: Facility Risk Mitigation

artículo científico publicado en 2018

Proceedings of the 2017 Viral Clearance Symposium, Session 2.1: DSP Unit Operations-Virus Filtration/Inactivation

artículo científico publicado en 2018

Proceedings of the 2017 Viral Clearance Symposium, Session 2.2: DSP Unit Operations-Purification Unit Operations

scientific article published on 20 July 2018

Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays

artículo científico publicado en 2020

Quantitative comparison of the cross-protection induced by tick-borne encephalitis virus vaccines based on European and Far Eastern virus subtypes

artículo científico publicado en 2011

Reduction of spiked porcine circovirus during the manufacture of a Vero cell-derived vaccine.

artículo científico publicado en 2014

Reflections on the emergence of chikungunya virus in the United States: time to revisit a successful paradigm for the safety of blood-derived therapies.

artículo científico publicado en 2015

Removal of small nonenveloped viruses by antibody-enhanced nanofiltration during the manufacture of plasma derivatives

artículo científico publicado en 2006

Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies

artículo científico publicado en 2009

SARS-CoV-2 and the safety margins of cell-based biological medicinal products

artículo científico publicado en 2020

Safety and immunogenicity of a vero cell culture-derived whole-virus influenza A(H5N1) vaccine in a pediatric population.

artículo científico publicado en 2013

Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: a randomized trial

artículo científico publicado en 2011

Secondary structure of DNA released from purified capsids of human parvovirus B19 under moderate denaturing conditions

artículo científico publicado en 2019

Selection of recombinant MVA by rescue of the essential D4R gene ⬇️

artículo científico publicado el 12 de diciembre de 2011

Synthesis of 'Nereid', a new phenol-free detergent to replace Triton X-100 in virus inactivation

artículo científico publicado en 2020

TT virus does not contaminate first-generation recombinant factor VIII concentrate

artículo científico publicado en 2002

The evolution of down-scale virus filtration equipment for virus clearance studies

artículo científico publicado en 2014

Tick-Borne Encephalitis Virus-Neutralizing Antibodies in Different Immunoglobulin Preparations ⬇️

artículo científico publicado el 29 de febrero de 2012

Tick-borne encephalitis virus vaccine as additional alternative neoantigen for the clinical immunologist's toolbox.

artículo científico publicado en 2012

Treatment of Ebola virus infection with antibodies from reconvalescent donors

artículo científico publicado en 2015

Truly continuous low pH viral inactivation for biopharmaceutical process integration

artículo científico publicado en 2020

Vectors Based on Modified Vaccinia Ankara Expressing Influenza H5N1 Hemagglutinin Induce Substantial Cross-Clade Protective Immunity ⬇️

artículo científico publicado el 24 de enero de 2011

Viral contamination in biologic manufacture and implications for emerging therapies

scientific article published on 27 April 2020

Virus & TSE safety forum 2008.

artículo científico publicado en 2009

Virus Filtration and Flow Variation: An Approach To Evaluate Any Potential Impact on Virus Retention

artículo científico publicado en 2016

Virus disinfection for biotechnology applications: Different effectiveness on surface versus in suspension

artículo científico publicado en 2020

Virus inactivation during the freeze-drying processes as used for the manufacture of plasma-derived medicinal products

artículo científico publicado en 2009

Virus susceptibility of Chinese hamster ovary (CHO) cells and detection of viral contaminations by adventitious agent testing

artículo científico publicado en 2010

West Nile virus and the safety of plasma derivatives: verification of high safety margins, and the validity of predictions based on model virus data

artículo científico publicado en 2003

West Nile virus infection in plasma of blood and plasma donors, United States

artículo científico publicado en 2009

West Nile virus neutralization by US plasma-derived immunoglobulin products

artículo científico publicado en 2007

Zika virus is not thermostable: very effective virus inactivation during heat treatment (pasteurization) of human serum albumin

artículo científico publicado en 2016

Lista de obras de

A Pandemic Influenza H1N1 Live Vaccine Based on Modified Vaccinia Ankara Is Highly Immunogenic and Protects Mice in Active and Passive Immunizations ⬇️

A Vero Cell–Derived Whole-Virus H5N1 Vaccine Effectively Induces Neuraminidase-Inhibiting Antibodies ⬇️

A cell culture-derived whole-virus H5N1 vaccine induces long-lasting cross-clade protective immunity in mice which is augmented by a homologous or heterologous booster vaccination ⬇️

A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolate ⬇️

A nonenveloped virus with a lipid envelope: hepatitis A virus as used in virus-reduction studies

A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans

A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.

Antibody-enhanced hepatitis E virus nanofiltration during the manufacture of human immunoglobulin

Blood transmission studies of prion infectivity in the squirrel monkey (Saimiri sciureus): the Baxter study

Characterization of 100 sequential SARS-CoV-2 convalescent plasma donations

Characterization of source plasma from self-identified vaccinated or convalescent donors during the 2009 H1N1 pandemic

Chikungunya virus and the safety of plasma products ⬇️

Clinical, neuropathological and immunohistochemical features of sporadic and variant forms of Creutzfeldt-Jakob disease in the squirrel monkey (Saimiri sciureus).

Continued use of poliovirus after eradication: hyper-attenuated strains as a safe alternative for release testing of human immunoglobulins

Continuous Solvent/Detergent Virus Inactivation Using a Packed-Bed Reactor

Contribution to safety of immunoglobulin and albumin from virus partitioning and inactivation by cold ethanol fractionation: a data collection from Plasma Protein Therapeutics Association member companies

Cytomegalovirus neutralization by hyperimmune and standard intravenous immunoglobulin preparations

Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells

Evaluation of different serological diagnostic methods for tick-borne encephalitis virus: enzyme-linked immunosorbent, immunofluorescence, and neutralization assay

H5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer model

Hepatitis A virus antibodies in immunoglobulin preparations

Hepatitis E virus and the safety of plasma products: investigations into the reduction capacity of manufacturing processes

Human IgG Subclasses: In Vitro Neutralization of and In Vivo Protection against West Nile Virus ⬇️

Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID mice

Immunoglobulins and virus antibody titers: of past needs, current requirements, and future options

Impact of vCJD on blood supply

In reply

Inactivation of hepatitis A variants during heat treatment (pasteurization) of human serum albumin ⬇️

Inactivation of parvovirus B19 during STIM-4 vapor heat treatment of three coagulation factor concentrates

Influence of Extraction Protocol on Physical Properties of Parvovirus B19 DNA ⬇️

MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 viruses

Measles Virus Neutralizing Antibodies in Intravenous Immunoglobulins:is an Increase by Re-Vaccination of Plasma Donors possible?

Measles virus neutralizing antibodies in immunoglobulin lots produced from plasma collected in Europe or the United States

Measuring the effectiveness of gaseous virus disinfectants

Meeting Report: 2013 PDA Virus & TSE Safety Forum

Meeting Report: 2015 PDA Virus & TSE Safety Forum

Meeting Report: PDA Virus and TSE Safety Forum.

Meeting report--workshop on virus removal by filtration: trends and new developments.

Meeting report-workshop on spike characterizations and virus removal by filtration: trends and new developments

Molecular Basis of the Divergent Immunogenicity of Two Pediatric Tick-Borne Encephalitis Virus Vaccines

Nanofiltration as a robust method contributing to viral safety of plasma-derived therapeutics: 20 years' experience of the plasma protein manufacturers

Neuraminidase-Inhibiting Antibody Response to H5N1 Virus Vaccination in Chronically Ill and Immunocompromised Patients

Neutralization of different echovirus serotypes by individual lots of intravenous immunoglobulin ⬇️

Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins

No SARS-CoV-2 neutralization by intravenous immunoglobulins produced from plasma collected before the 2020 pandemic

Parallel evaluation of broad virus detection methods

Pre-Clinical Efficacy and Safety of Experimental Vaccines Based on Non-Replicating Vaccinia Vectors against Yellow Fever ⬇️

Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.

Preparation of commercial quantities of a hyperimmune human intravenous immunoglobulin preparation against an emerging infectious disease: the example of pandemic H1N1 influenza ⬇️

Prion removal capacity of plasma protein manufacturing processes: a data collection from PPTA member companies

Proceedings of the 2017 Viral Clearance Symposium Session 5: Facility Risk Mitigation

Proceedings of the 2017 Viral Clearance Symposium, Session 2.1: DSP Unit Operations-Virus Filtration/Inactivation

Proceedings of the 2017 Viral Clearance Symposium, Session 2.2: DSP Unit Operations-Purification Unit Operations

Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays

Quantitative comparison of the cross-protection induced by tick-borne encephalitis virus vaccines based on European and Far Eastern virus subtypes

Reduction of spiked porcine circovirus during the manufacture of a Vero cell-derived vaccine.

Reflections on the emergence of chikungunya virus in the United States: time to revisit a successful paradigm for the safety of blood-derived therapies.

Removal of small nonenveloped viruses by antibody-enhanced nanofiltration during the manufacture of plasma derivatives

Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies

SARS-CoV-2 and the safety margins of cell-based biological medicinal products

Safety and immunogenicity of a vero cell culture-derived whole-virus influenza A(H5N1) vaccine in a pediatric population.

Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: a randomized trial

Secondary structure of DNA released from purified capsids of human parvovirus B19 under moderate denaturing conditions

Selection of recombinant MVA by rescue of the essential D4R gene ⬇️

Synthesis of 'Nereid', a new phenol-free detergent to replace Triton X-100 in virus inactivation

TT virus does not contaminate first-generation recombinant factor VIII concentrate

The evolution of down-scale virus filtration equipment for virus clearance studies

Tick-Borne Encephalitis Virus-Neutralizing Antibodies in Different Immunoglobulin Preparations ⬇️

Tick-borne encephalitis virus vaccine as additional alternative neoantigen for the clinical immunologist's toolbox.

Treatment of Ebola virus infection with antibodies from reconvalescent donors

Truly continuous low pH viral inactivation for biopharmaceutical process integration

Vectors Based on Modified Vaccinia Ankara Expressing Influenza H5N1 Hemagglutinin Induce Substantial Cross-Clade Protective Immunity ⬇️

Viral contamination in biologic manufacture and implications for emerging therapies

Virus & TSE safety forum 2008.

Virus Filtration and Flow Variation: An Approach To Evaluate Any Potential Impact on Virus Retention

Virus disinfection for biotechnology applications: Different effectiveness on surface versus in suspension

Virus inactivation during the freeze-drying processes as used for the manufacture of plasma-derived medicinal products

Virus susceptibility of Chinese hamster ovary (CHO) cells and detection of viral contaminations by adventitious agent testing

West Nile virus and the safety of plasma derivatives: verification of high safety margins, and the validity of predictions based on model virus data